Fig. 2From: Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of TunisiaBRCA mutation rate (%) in all BC (a), in all OC (b), and in TNBC (c) patients divided according to age at diagnosis (≤ 30, 31–40, 41–50, and ≥ 51 years old)Back to article page